Pharma Stocks mein Girawat Kaafi Time se chal rahi hai aur last 30 months mein 28% down ho chuka hai.
During the same period, Lupin corrected 46 percent, Sun Pharma 40 percent and Cipla 25 percent.
Global brokerage house Morgan Stanley ne Pharme ke 2 Stocks par apni report di hai aur apna bullish opinion diya hai.
2 Pharma Stocks could give 32-47% return –
1 – Morgan Stanley kaa manna hai ki Sun Pharma abhi jis price par available wo bahut hi attractive hai.
Sun Pharma mein Yahan se 32 percent ki growth dekhne ko mil sakti hai aur 505 kaa Target diya hai.
2 – Morgan Stanley ne Sun pharma ke alawa ek aur pharma ke Stock ko lekar Bullish opinion diya hai.
Global Brokerage Firm kaa manna hai ki Lupin mein bhi achchi Opportunity mil sakti hai.
Lupin has 47 percent potential upside from current levels.
The stock is trading at 20-25 percent discount to its historical valuation.
We believe that the stock can rerate, driven by an earnings recovery.
Lupin, as well as Sun Pharma, corrected 67 percent each from their all-time highs touched in October and August 2015 respectively.
Disclaimer: The above report is compiled from information available on public platforms.
Aslipaisa.com advises you to check carefully and get experts advice for investments.